CHVI President Cyndy Nayer is quoted in an article on HartfordBusiness.com, praising an unusual pay-for-performance contract between Cigna and Merck. The deal is this: Cigna gets discounts on Merck diabetes drugs Januvia and Janumet if covered patients take their drugs as prescribed, and even more discounts if patients’ blood sugar drops — on any regimen, not just the Merck-made drugs. Nayer said:
“It’s very significant for the industry. There is a commitment on both sides to improve the
health of the population.”
Read the full story here or download it as a PDF.
Tags: adherence, Cigna, diabetes, health improvement, Merck, Nayer, OBC, outcomes-based contracting, patient-centered
Follow CHVI on Facebook